Skip to content

Allotment

Influx Healthtech Limited

Influx Healthtech Limited launched a book-built IPO to raise ₹58.57 crore, comprising a fresh issue of 0.50 crore shares aggregating to ₹48.00 crore and an offer for sale of 0.11 crore shares aggregating to ₹10.56 crore. The IPO was open for bidding from June 18 to June 20, 2025, with allotment finalized on June 23, 2025. The shares were subsequently listed on the NSE SME platform on June 25, 2025.

The IPO price band was set at ₹96 per share, with a lot size of 1,200 shares per application. Retail investors were required to invest a minimum of ₹1,09,200 for one lot, while High Net Worth Investors (HNI) needed to apply for a minimum of 2 lots (2,400 shares), totaling ₹2,30,400.

Key Participants

Book Running Lead Manager: Rarever Financial Advisors Pvt. Ltd.

Registrar: Maashitla Securities Pvt. Ltd.

Market Maker: R.K. Stock Holding Pvt. Ltd.

The IPO provided investors an opportunity to participate in the growth of Influx Healthtech Limited, a company focused on advancing healthcare solutions and technologies to meet the evolving demands of the healthtech sector.

Influx Healthtech Limited IPO & Charts
₹96

0%

Open

₹96

HIgh - Low

₹96

Previous Close

₹96

Total Traded Value

0

52 Weeks High

₹96

52 Weeks Low

₹96

Updates On

Jun 12, 2025

IPO. Open

Jun 18, 2026

IPO. Close

Jun 20, 2026

IPO. Price

₹96.00

IPO Market price

₹222.24 Cr

IPO Details

IPO Date 25 Jun
IPO Listing Date 25 Jun
IPO Face Value ₹10 per share
IPO Price Range ₹96.00
IPO Issue Size 61,00,800 shares
IPO Sale Type Fresh Capital & OFS
Employee Discount -
IPO Issue Type Bookbuilding IPO
IPO Listing NSE SME Platform
Share Holding Pre Issue 1,81,50,000 shares

IPO Timeline

IPO Open Date 18 Jun
IPO Close Date 20 Jun
IPO Allotment (Tentative) 23 Jun
Refunds 24 Jun
Credit to Demat Account 24 Jun
IPO Listing Date 25 Jun

IPO Reservation

Category Offer
QIB Shares Offered 28,95,600 Shares
NII (HNI) Shares Offered 8,70,000 Shares
Retail Shares Offered 20,29,200 Shares

IPO Lot Size

Investors can bid for a minimum of 1,200 shares, with additional bids in multiples of 1,200 shares.

Application Lots Share Amount
Retail (Min) 1 1,200 ₹1,15,200
Retail (Max) 1 1,200 ₹1,15,200
S-HNI (Min) 2 2,400 ₹2,30,400
S-HNI (Max) - - -
B-HNI (Min) - - -
About Company

Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specializing in contract manufacturing. Operating as a trusted CDMO (Contract Development and Manufacturing Organization), the company provides specialized services to clients across multiple industries, enabling them to efficiently bring their products to market.

Manufacturing Facilities & Operations
The company has three state-of-the-art manufacturing facilities located in Thane, Maharashtra, covering areas of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. respectively. These facilities support a wide range of pharmaceutical, nutraceutical, cosmetic, and homecare products, ensuring high-quality production standards and regulatory compliance.

Product Portfolio
Influx Healthtech offers a diverse product range, including:

Pharmaceuticals: Tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules

Cosmetics & Personal Care: Skin care, body care, hair care, beard care solutions, face masks, soaps

Nutraceuticals & Supplements: Gym/sports supplements, Ayurvedic/herbal formulations, veterinary feed supplements

Homecare Solutions

The company supports nutraceutical and cosmetic firms with end-to-end services, including product development, manufacturing, and regulatory support, allowing clients to focus on formulation and commercialization.

Workforce & Competitive Strengths
As of June 11, 2025, Influx Healthtech employs 163 permanent employees. Its key competitive strengths include a diversified product portfolio, a broad and varied clientele, stringent quality assurance/quality control measures, and a team of experienced promoters and management professionals.

Influx Healthtech Ltd. reported a 5% increase in revenue and a 19% growth in profit after tax (PAT) for the financial year ending March 31, 2025, compared to the previous year ending March 31, 2024.

Company Financials (Consolidated)

Assets 70.3 41.1 28.3
Total Income 104.99 100.1 76.07
Profit After Tax 13.37 11.22 7.2
EBITDA - - -
NET Worth 36.15 22.87 11.65
Reserves and Surplus 18 22.85 11.63
Total Borrowing 0.22 0.32 0.8

Key Performance Indicator (KPI)

ROE 36.98%
ROCE 49.17%
Debt/Equity 0.01
RoNW 36.98%
PAT Margin 12.75%
EBITDA Margin 19.62%
Price to Book Value 4.82
IPO Objective

IPO Objects of the Issue

S.No. Objects of the ipo Resources Detail IPO Amount
1 Funding capital expenditure requirements for the purchase of equipment/machineries -
2 To meet out the expenses of Working Capital Requirement -
3 To meet out the General Corporate Purposes; 5.44
4 Offer for Sale (OFS) -

Contact Details

Influx Healthtech Ltd. Address
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West,
Mumbai, Maharashtra, 400067
+91 7045997809
cs@influxhealthtech.com
https://influxhealthtech.com/

Detail Registrar

IPO Registrar

Maashitla Securities Pvt.Ltd.
+91-11-45121795-96
investor.ipo@maashitla.com
https://maashitla.com/allotment-status/public-issues

Compare:

Back To Top